Back to company

SIMULPHARMA ApS: Financial statements 2016

CVR: 32832075

SIMULPHARMA ApS (CVR 32832075) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,077,279 and a net result of DKK 107,480 compared with DKK 4,469 the year before. That is an increase of 21.8% compared with the year before. Equity amounted to DKK 162,583. The solvency ratio was 61.1%.

Gross Profit
1,077,279 kr.
Profit/Loss
107,480 kr.
Equity
162,583 kr.
Total Assets
265,968 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-1.1 mio.107 t.163 t.-
2015-885 t.4 t.55 t.-
2014-774 t.42651 t.-
2013-526 t.2 t.50 t.-
2012-639 t.18 t.49 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is SIMULPHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

SIMULPHARMA ApS: The 2015 annual report is outJun 8, 2016

SIMULPHARMA ApS has published its annual report for 2015. Gross profit came to DKK 884,625, and the net result was DKK 4,469.

About SIMULPHARMA ApS

SIMULPHARMA ApS is a Danish company of the type Anpartsselskab based in Birkerød, founded in 2010. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Gunnlaugur Halldorsson. The company is owned by Gunnlaugur Halldorsson. The company has 1 employee. In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. Equity amounted to DKK 63,769.